Avextra Archives - Green Market Report

StaffMarch 15, 2023
daily-hit.jpg

4min7040

The Daily Hit is a recap of the top financial news stories for March 15, 2023.

On the Site

TerrAscend Looks to Create New Holding Umbrella, List on TSX

TerrAscend Corp. (CSE: TER) (OTCQX: TRSSF) submitted an application to list its shares on the Toronto Stock Exchange, with the creation of a separate holding company likely serving as the vehicle for the major exchange upgrade. Read more here.

Chicago Cannabis Leader Verano’s Sammy Dorf

Sammy Dorf is co-founder of Chicago-based Verano Holdings (OTC: VRNOF), one of the largest cannabis companies in the nation, boasting more than 120 dispensaries in 13 states, 14 cultivation and production facilities, and nearly 4,000 employees. Crain’s Chicago Business sat down with Dorf to talk about the path he took to becoming a cannabis business leader. Read more here.

The Can’t Miss Cannabis Show in NYC? The GMR Women’s Summit

Cannabis stocks have joined tech and other industries with a huge dip and it is pulling down all the other companies – including startups, privately owned, and small service firms…but there is hope. To help women have a bigger impact, Green Market Report has chosen Women’s History Month as the perfect time to host its second annual Women’s Summit. Read more here.

The 2023 Green Market Report Women’s Summit takes place March 23 in New York City. Secure your seat today!

European Cannabis Company Avextra Raises 17 Million Euro

Privately-owned Avextra AG, a leader in the European medical cannabis market, is proud to announce the closing of an EU 17 million capital raise with support from existing investors, the full management team, and additional European investors. Read more here.

In Other News

Temescal Wellness

Temescal Wellness has designated April 20 (4/20) as a paid holiday for team members at its dispensary locations in Massachusetts, production facilities, and corporate office. Read more here.

Lowell Farms

Lowell Farms Inc. (CSE:LOWL) (OTCQX:LOWLF), a lvertically integrated, California-based cannabis company, entered into a binding letter of intent with the company’s existing noteholders. The company has agreed to sell its “Lowell Smokes” and “35s” brands and associated intellectual property to Lowell Brands LLC, a newly formed Delaware limited liability company and to assign the related license agreements and material contracts. Read more here.

GrowGeneration Corp.

GrowGeneration Corp. (Nasdaq: GRWG), a chain of specialty hydroponic and organic garden centers in the United States, reported net revenue for 2022 decreased 34.2% to $278.2 million. The decline was expected as the final result fell at the high end of the company’s previous guidance range. Read more here.


Debra BorchardtMarch 15, 2023
shutterstock_1583326303.jpg

3min10320

Privately-owned Avextra AG, a leader in the European medical cannabis market, is proud to announce the closing of an EU 17 million capital raise with support from existing investors, the full management team, and additional European investors. The company said the money will be used to expand the sales of Avextra’s current product portfolio into new markets across Europe and further enhance market development in Germany.

The capital will accelerate Avextra’s development of new Cannabis-based medicines and IP, as well as support the continued expansion of its R&D and growth in Portugal. Avextra said it will launch the next phase of patient studies and clinical trials with proprietary products in specific indications. The investment marks a significant milestone in Avextra’s journey to establish itself as one of the few R&D and IP-focused players in the global cannabis market.

“We are very proud of the confidence investors have shown us. We will continue building on our success to make Avextra a leader in compound medicines in Germany and selected European geographies while also accelerating our unique path towards IP and Rx products,” said Bernhard Babel, Co-CEO of Avextra AG. “Avextra will begin several clinical trials in 2023 in Germany and Portugal. This is a testament to the innovation potential inherent in the European cannabis market.”

Avextra cultivates proprietary genetics and runs an ambitious R&D program in Germany and Portugal. The company manufactures cannabis-based medicines in a dedicated 100 000 ft2 state-of-the-art facility in the heart of the German pharmaceutical industry to develop innovative, effective and regulator-approved cannabis-based medicines.

Founded in 2019 and based out of Germany, the company focuses on the production of precisely formulated Cannabis-based medicines. Avextra controls the entire value chain – from cultivation in Portugal to EU-GMP certified extraction and manufacturing Germany. Avextra operates across continental Europe through an expansive distribution network of multiple channels and assets strategically developed for these key markets.


Get the latest cannabis news delivered right to your inbox

The Morning Rise

Unpack the industry with the daily cannabis newsletter for business leaders.

 Sign up


About Us

The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis


READ MORE



Recent Tweets

Back to Top

Get the latest cannabis news delivered right to your inbox

The Morning Rise

Unpack the industry with the daily cannabis newsletter for business leaders.